Presenting the future of specialty pharmacy at AXS24

AXS24, the 20th Asembia Summit, is fast approaching its start date of Sunday, April 28, with another record-breaking event expected. Last year, the attendance was close to 8000! The conference, which will take place at Wynn & Encore Las Vegas, will run until Thursday, May 2.

More than 7000 industry attendees, more than 1200 organizations and more than 200 exhibitors will descend on Las Vegas, representing all facets of the pharmaceutical supply chain: pharmacies, pharmaceutical manufacturers, health plans, pharmacy benefit managers (PBMs) , technology, defense and politics, just to name a few. Attendees are again expected to include market access professionals, pharmacy owners and operators, industry consultants, suite executives, nurses, physicians, pharmacists and managed care leadership.

I love Asambia because it’s a great opportunity to connect with clients, former colleagues and friends from across the industry, said Sarah Butler, Chief Commercial Officer at ADVI Health, in an interview with The American Journal of Managed Care ^{(AJMC) before the conference. For me, this is always the highlight every year.}

This annual summit’s continued commitment to promoting and improving the world of specialty pharmacy and ensuring that patients remain the top priority will be evident both in the daily sessions and in the continuing education (CE) opportunities it presents each day. by Pharmacy Times Continuing Education, a subsidiary of MJH Life Sciences^{parent company of AJMC.}

I’m looking forward to the sessions on Medicare Part D and what Part D plans could do next year as they react to changes in the Part D benefit redesign, said Lindsay Greenleaf, vice president and leader of solutions, federal and state policy, ADVI. Health. We’ve had data showing plans’ reactions to the changes as far back as the 2024 benefit year.

During the first full day of conference activities, morning educational opportunities will include integrating biologic therapy and reducing barriers to access, addressing food allergies and myasthenia gravis in the value-based space . Afternoon sessions include The Specialty Pipeline, presented by Ray Tancredi, RPh, MBA, Divisional Vice President, Specialty Pharmacy Development Brand Rx/Vaccine Purchasing, Walgreens, who provided a 2023 update last year; Summit Rookie Camp, aimed at introducing newcomers and rising stars to today’s niche market; and State of the Payer 2024, which will include topics such as patient and drug availability and the policy landscape.

A highlight to kick off Day 2 is the General Session, which will feature 3 speakers this year: Nick Webb, CEO of LeaderLogic LLC; Doug Long, vice president of industry relations at IQVIA; and Patrick Lupo, Group Vice President, Commerce and Specialty Pharmacy, Walgreens. The keynote address will be delivered by retired Navy Admiral William McRaven, also former chancellor and CEO of the University of Texas System. The day’s educational opportunities will inform about breast cancer, the therapeutic landscape in the practice of pharmacy, and navigating next-generation therapies. Sessions will address 2024 electoral policy issues, payment models, market access for biotech launches, value-based procurement, rare disease therapeutics, the changing biosimilar industry.

Wednesday, May 1, will begin with a panel exploring the current impact of the Inflation Reduction Act, a particularly hot topic in this election year, and will be followed by discussions on artificial intelligence to increase profitability of the industry, the trends in favor of specialized medicines. design, advancing women’s health equity, navigating the regulatory landscape, remote patient management, and rare disease pricing strategy. CE on day 3 will address innovations in prostate cancer therapeutics and the role of the specialty pharmacist in the space.

Assembias AXS24 Summit’s comprehensive offering will address critical issues facing the specialty pharmacy industry, demonstrating a commitment to improving specialty pharmacy and prioritizing and optimizing patient care.

You can check the entire conference agenda here.